Scientist/Sr./Principal Scientist, ADC & Translational Research
Oxfordbiotherapeutics
About this role
Oxford BioTherapeutics (OBT) is a biotechnology company focused on developing innovative antibody-drug conjugate (ADC) therapies for cancer. The company engages in discovery, biological evaluation, and preclinical studies to advance targeted cancer treatments, collaborating across multiple scientific disciplines and utilizing advanced technologies.
Skills
About Oxfordbiotherapeutics
oxfordbiotherapeutics.comOxford BioTherapeutics is a biotechnology company focused on developing first‑in‑class oncology therapies. They pioneer targeted approaches including Antibody‑Drug Conjugates (ADCs), immuno‑oncology agents, T‑Cell Engagers (TCEs), and radiopharmaceuticals. The company advances a pipeline driven by translational science and strategic partnerships to accelerate delivery of novel cancer treatments to patients.
About Oxfordbiotherapeutics
Headquarters
San Francisco, CA
Company Size
201-500 employees
Founded
2018
Industry
Technology
Glassdoor Rating
4.2 / 5
Leadership Team
Sarah Johnson
Chief Executive Officer
Michael Chen
Chief Technology Officer
Emily Williams
VP of Engineering
David Rodriguez
VP of Product
Jessica Thompson
Chief Financial Officer
Andrew Park
VP of Sales
Unlock Company Insights
View leadership team, funding history,
and employee contacts for Oxfordbiotherapeutics.
Salary
$130k – $200k
per year
More jobs at Oxfordbiotherapeutics
Similar Jobs
Principal Scientist, Discovery Chemistry
0468 BMS Polska Sp. z o.o.
Director, Medicinal Chemistry, ADC Group Leader
Gilead Sciences
ADC Sr. Brand Manager
American Association of Physicists in Medicine
Senior Scientist II, ADC/AOC Conjugation
AbbVie
Bench Scientist
Arcotech
Scientist II, Cancer Pharmacology, Translational Research
Revolution Medicines